The 38th Congress of Société Internationale d’Urologie, Seoul, Korea, 4/10/2018-07/10/2018 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 24 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Attn: All abstract authors. If you registered by the presenting author deadline, please click here and scroll down after presentation types to view ePoster upload instructions. Session details (if applicable) will be available upon upload.
The 38th Congress of the Société Internationale d'Urologie is compliant with the Korean Academy of Medical Sciences (KAMS) Fair Trade Competition Agreement and is therefore compliant with the Korean Research-Based Pharmaceutical Industry Association (KRPIA) guidelines, the Korean Medical Devices Association (KMDIA) code of ethics and the The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) guidelines.
The 38th Congress of the Société Internationale d'Urologie is compliant with the provisions of the MedTech Europe Code of Ethical Business Practice. For more information, please click HERE
The Cambridge Prostate mpMRI & Biopsy Course is an established international workshop has traditionally addressed the approach to learning the skills required for this new diagnostic tool and its application using guided biopsies in a multidisciplinary environment involving Radiologists, Urologists and Pathologists.
Through a combination of lectures, practical cases, discussions and workshops the course sets out to share knowledge on the quality and advantages of the Prostate MRI which have re-defined prostate diagnostic practice in recent years. Modules for beginners and advanced readers will be provided.
Places for the course are limited and will be handled on a first come first serve basis. For more information please visit http://www.cambridge-mri-course.org/
Tremendous advancements have been made in diagnosis and treatment with the recent FDA approval of a targeted therapy for metastatic bladder cancer with FGFR3 or FGFR2 genetic alterations, two combination immunotherapy-targeted therapies as first-line treatment for advanced RCC, as well as advances in diagnostics and immunotherapy research for prostate cancer
Take advantage of this highly anticipated event and immerse yourself in the evolving landscape of urological cancer care.
For more information and to register, click here. Space is limited!
Prague, Czech Republic | 23rd to 25th January 2020
More information here.
Gopal Badlani, United States, Co-Chair
Rajeev Kumar, India, Co-Chair